The potential of aptamers as anticoagulants
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 15 (1), 41-45
- https://doi.org/10.1016/j.tcm.2005.01.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degenerationOphthalmology, 2003
- PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2002
- Anticoagulation TherapyHematology-American Society Hematology Education Program, 2001
- Thrombin signalling and protease-activated receptorsNature, 2000
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- DIVERSITY OF OLIGONUCLEOTIDE FUNCTIONSAnnual Review of Biochemistry, 1995
- Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Selection of single-stranded DNA molecules that bind and inhibit human thrombinNature, 1992
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990